Furthermore, we indicated that the K70Q mutant of ALDH1L2 disturbs cellular redox and serine metabolism, inhibiting CRC cell proliferation and sensitizing CRC cells to 5-Fu treatment both in vitro and in vivo. Here, ALDH1L2 is linked to colorectal carcinoma.